Icosagen (Estonia)

Icosagen (Estonia)

Icosagen is an Estonian biotechnology companies providing custom research programs and services to the Biopharmaceutical industry, including antibody discovery, protein production, and GMP manufacturing. Formed in 1999 as Quattromed AS, it was renamed Icosagen in 2009. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Icosagen (Estonia), Estonia, covering academic research published from 2004 to 2024. Read More.


Open Access Percentage

77%


Total
Publications

75


Total Open
Publications

58


Total
Citations

1.3K


Open Access
Percentage

77%


Total
Publications

75


Total Open
Publications

58


Total
Citations

1.3K

Wikipedia

Website

download

Breakdown

15% 54% 8% 23%

Publisher Open

15%

Both

54%

Other Platform Open

8%

Closed

23%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01234567891011Total Publications
200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

59%OA Journal

OA Journal 59%

31

Hybrid 33%

17

No Guarantees 8%

4

Other Platform Open

Domain 77%

36

Institution 26%

12

Other Internet 17%

8

Public 15%

7

Preprint 11%

5

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
36
Europe PMC
Domain
17
Semantic Scholar
Public
7
KU Leuven - Lirias
Institution
6
University of Oslo - Duo Research Archive
Institution
4
DOI
Other Internet
4
Maastricht University - Research Publications
Institution
3
bioRxiv
Preprint
3
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes
Institution
2
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART
Other Internet
2
1 / 3

Data updated 7 April 2025

Share

Share

Share